Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:controls |
placebo
|
| gptkbp:duration |
24 months
|
| gptkbp:explores |
effect of nutritional intervention
|
| gptkbp:focusesOn |
gptkb:Alzheimer's_disease
|
| gptkbp:foundIn |
no significant effect on primary endpoint
|
| gptkbp:fundedBy |
European Union FP7
|
| https://www.w3.org/2000/01/rdf-schema#label |
LipiDiDiet study
|
| gptkbp:intervention |
gptkb:Fortasyn_Connect
|
| gptkbp:location |
gptkb:Europe
|
| gptkbp:population |
prodromal Alzheimer's disease patients
|
| gptkbp:principalInvestigator |
Miia Kivipelto
|
| gptkbp:publishedIn |
gptkb:The_Lancet_Neurology
|
| gptkbp:result |
cognitive decline
|
| gptkbp:secondaryFinding |
benefit in some secondary endpoints
|
| gptkbp:startYear |
2009
|
| gptkbp:studyType |
gptkb:clinical_trial
|
| gptkbp:bfsParent |
gptkb:Souvenaid
|
| gptkbp:bfsLayer |
7
|